PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21773063-0	2011	Models for the prediction of receptor tyrosine kinase inhibitory activity of substituted 3-aminoindazole analogues.	1H-Indazol-3-amine	89-104	ret proto-oncogene	Homo sapiens	29-53	
17343372-0	2007	Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N"-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor.	1H-Indazol-3-amine	97-112	ret proto-oncogene	Homo sapiens	147-171	
17343372-1	2007	In our continued efforts to search for potent and novel receptor tyrosine kinase (RTK) inhibitors as potential anticancer agents, we discovered, through a structure-based design, that 3-aminoindazole could serve as an efficient hinge-binding template for kinase inhibitors.	1H-Indazol-3-amine	184-199	ret proto-oncogene	Homo sapiens	56-80	
17343372-1	2007	In our continued efforts to search for potent and novel receptor tyrosine kinase (RTK) inhibitors as potential anticancer agents, we discovered, through a structure-based design, that 3-aminoindazole could serve as an efficient hinge-binding template for kinase inhibitors.	1H-Indazol-3-amine	184-199	ret proto-oncogene	Homo sapiens	82-85